After years of delays and debate, 2024 was the year when several health initiatives started to move forward. And advocates ...

There were already signs from cardiovascular outcome studies that SGLT2 inhibitors like Farxiga and Boehringer Ingelheim/Eli Lilly’s Jardiance (empagliflozin) could preserve renal function in ...

In contrast, only about 9% of folks without diabetes up to age 70 develop dementia. So, it's very welcome news that SGLT2 inhibitors, such as Farxiga, Jardiance, and Invokana, that are approved to ...

More than 110,000 North Carolinians are projected to benefit from a $2,000 annual cap on out-of-pocket costs for covered prescription drugs for Medicare Part D participants.

AstraZeneca's SGLT2 inhibitor Farxiga has hit the mark in a phase 3 heart failure trial that brings it back into contention with its main rival Jardiance from Boehringer Ingelheim and Eli Lilly ...

sources say "It is medically necessary that Jessica use Farxiga or Jardiance as part of her heart failure." But Horizon Blue Cross Blue Shield of New Jersey denied coverage for the medicine which ...

The quest for effective weight loss solutions has never been more urgent, with millions of people worldwide struggling to ...

Ozempic's ads were 57% more effective in driving consumer engagement on streaming TV than on linear TV during Q3.

In a year when GLP-1 drugs were a best-selling, buzzy phenomenon, Novo Nordisk’s ad spend for Ozempic in streaming TV has been paying off. The brand’s ads were 57% more effective in driving ...

"The negotiations included two pairs of drugs that belonged to the same drug class -- Eliquis [apixaban]/Xarelto [rivaroxaban] and Farxiga [dapagliflozin]/Jardiance [empagliflozin]. In each case ...